Insurance for Biotechs: Property 2741009234941582512-blid-7852522371938435522

วาสนาเผย 10 เรื่องพระปรีชาสามารถ ด้านการทหาร ของ “สมเด็จพระราชินีสุทิดา”สมเด็จพระราชินีผู้ทรงเป็นนา

 
   

Biotechnology companies and organisations display distinctive features and, from an insurance perspective, uncommon risks. Quite apart from liability risks associated with the testing of investigational drugs, biotech companies are faced with some unique exposures that could delay development, and possibly, the achievement of milestones. Such delays could hamper the ability of the company to raise additional funds and therefore its ability to continue as a going concern.

Comments

Popular posts from this blog